Endogenous and induced angiogenic characteristics of human chorion-derived stem cells

Cell Biology International

Volumn 36, Issue 12, 2012, Pages 1145-1153

  Nur Fariha, Mohd Manzor ^a   Chua, Kien Hui ^a   Tan, Geok Chin ^a   Lim, Yun Hsuen ^b   Hayati, Abdul Rahman ^a,c  

^a DEPARTMENT OF PHARMACOLOGY   (Malaysia)

^b Hospital Kebangsaan Malaysia   (Malaysia)

^c UNIVERSITI SAINS ISLAM MALAYSIA   (Malaysia)

Author keywords

Angiogenesis; Cell based therapy; Fetal stem cells; Growth factors; Ischaemia; Placenta

Indexed keywords

ANGIOPOIETIN 1; BREAST CANCER RESISTANCE PROTEIN; CD31 ANTIGEN; CD34 ANTIGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBROBLAST GROWTH FACTOR 2; OCTAMER TRANSCRIPTION FACTOR 4; PLACENTAL GROWTH FACTOR; SCATTER FACTOR; TRANSCRIPTION FACTOR NANOG; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; VON WILLEBRAND FACTOR;

ABCG2 GENE; ANGIOGENESIS; ANGIOPOIETIN 1 GENE; ARTICLE; BASIC FIBROBLAST GROWTH FACTOR GENE; BST 1 GENE; CD34 GENE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CHORION DERIVED STEM CELL; CONTROLLED STUDY; ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE; FZD9 GENE; GENE; GENE FUNCTION; GENE SEQUENCE; GENETIC ASSOCIATION; HEPATOCYTE GROWTH FACTOR GENE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; NANOG GENE; NUCLEOTIDE SEQUENCE; OCTAMER BINDING PROTEIN 4 GENE; PLACENTAL GROWTH FACTOR GENE; PLATELET ENDOTHELIAL CELL ADHESION MOLECULE 1 GENE; POLYMERASE CHAIN REACTION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STEM CELL; VASCULAR ENDOTHELIAL CADHERIN GENE; VASCULAR ENDOTHELIAL GROWTH FACTOR GENE; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 GENE; VON WILLEBRAND FACTOR GENE;

MUS MUSCULUS;

EID: 84871941325     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20120044     Document Type: Article

References (30)

1. Alviano F, Fossati V, Marchionni C, Arpinati M, Bonsi L, Franchina M et al. Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro. BMC Dev Biol 2007;7:11.
2. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-7.
3. Autiero M, Luttun A, Tjwa M, Carmeliet P. Placental growth factor and its receptor, vascular endothelial growth factor receptor 1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders. J Thromb Haemost 2003;1:1356-70.
4. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003;114:763-76.
5. Bobek V, Taltynov O, Pinterova D, Kolostova K. Gene therapy of the ischemic lower limb-therapeutic angiogenesis. Vasc Pharmacol 2006;44:395-405.
6. Cao Y, Sun Z, Liao L, Meng Y, Han Q, Zhao RC. Human adipose tissuederived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem Biophys Res Commun 2005;332:370-9.
7. Caplan AI. All MSCs are pericytes? Cell Stem Cell 2008;3:229-30. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003;9:653-60.
8. Carmeliet P, Moons L, Luttun A, Compernolle V, Wu Y, Bono F et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 2001;7:575-83.
9. Chhokar V, Tucker AL. Angiogenesis: Basic Mechanisms and Clinical applications. SAGE Publications; 2003. p. 253.
10. Folkman J. Angiogenic therapy of the human heart. Circulation 1998.97:628-9
11. Hu CH, Wu GF, Wang XQ, Yang YH, Du ZM, He XH et al. Transplanted human umbilical cord blood mononuclear cells improve left ventricular function through angiogenesis in myocardial infarction. Chin Med J 2006;119:1499-506.
12. Iwaguro H, Yamaguchi J, Kalka C, Murasawa S, Masuda H, Hayashi S et al. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 2002;105:732-8.
13. Kanda S, Miyata Y, Kanetake H. Role of focal adhesion formation in migration and morphogenesis of endothelial cells. Cell Signal 2004a;16:1273-81.
14. Kanda S, Miyata Y, Kanetake H. Fibroblast growth factor-2-mediated capillary morphogenesis of endothelial cells requires signals via Flt- 1/vascular endothelial growth factor receptor-1. J Biol Chem 2004b;279:4007-16.
15. Losordo DW, Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease. Circulation 2004;109:2692-7.
16. Manzor N, Chua K, Tan G, Tan A, Abdul RH. Augmentation of angiogenic and endothelial associated gene expression by EDM50 in human chorion-derived stem cells. Med J Malays 2008;63:11-2.
17. Marchionni C, Bonsi L, Alviano F, Lanzoni G, Di Tullio A, Costa R et al. Angiogenic potential of human dental pulp stromal (stem) cells. Int J Immunopathol Pharmacol 2009;22:699-706.
18. Milkiewicz M, Ispanovic E, Doyle JL, Haas TL. Regulators of angiogenesis and strategies for their therapeutic manipulation. Int J Biochem Cell Biol 2006;38:333-57.
19. Murohara T. Autologous adipose tissue as a new source of progenitor cells for therapeutic angiogenesis. J Cardiol 2009;53:155-63.
20. Nakagami H, Maeda K, Morishita R, Iguchi S, Nishikawa T, Takami Y et al. Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells. Arterioscler Thromb Vasc Biol 2005;25:2542-7.
21. Nur Fariha MM, Chua KH, Tan GC, Tan AE, Hayati AR. Human chorionderived stem cells: changes in stem cell properties during serial passage. Cytotherapy 2011;13:582-93.
22. Park Y, Kim J, Lee SJ, Choi IY, Park SJ, Lee SR et al. Human feeder cells can support the undifferentiated growth of human and mouse embryonic stem cells using their own basic fibroblast growth factors. Stem Cells Dev 2010;20:1901-10.
23. Peters KG, Kontos CD, Lin PC, Wong AL, Rao P, Huang L et al. Functional significance of Tie2 signaling in the adult vasculature. Recent Prog Horm Res 2004;59:51-71.
24. Ruel M, Sellke FW. Angiogenic protein therapy. Elsevier; 2003. p. 222-35.
25. Sieveking DP, Ng MKC. Cell therapies for therapeutic angiogenesis: back to the bench. Vasc Med 2009;14:153-66.
26. Stegmann TJ, Hoppert T, Schneider A, Gemeinhardt S, Kö cher M, Ibing R et al. Induction of myocardial neoangiogenesis by human growth factors. A new therapeutic approach in coronary heart disease. Herz. 2000;25:589-99.
27. Traktuev DO, Prater DN, Merfeld-Clauss S, Sanjeevaiah AR, Murphy M, Johnstone BH et al. Robust functional vascular network formation in vivo by cooperation of adipose progenitor and endothelial cells. Circ Res 2009;104:1410-20.
28. Yeh JL, Giordano FJ. Gene-based Therapeutic Angiogenesis. Elsevier; 2003. p. 236-49.
29. Zachary I. VEGF signalling: integration and multi-tasking in endothelial cell biology. Biochem Soc Trans 2003;2003;31:1171-7.
30. Zanetta L, Marcus SG, Vasile J, Dobryansky M, Cohen H, Eng K et al. Expression of von Willebrand factor, an endothelial cell marker, is up regulated by angiogenesis factors: a potential method for objective assessment of tumor angiogenesis. Int J Cancer 2000;85:281-8.